Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Espinosa

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cancer Cell|June 21, 2024
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumorsGabriel Espinosa-Carrasco, Edison Chiu, Aurora Scrivo, et al.
Theranostics|January 19, 2018
Gilz-Activin A as a Novel Signaling Axis Orchestrating Mesenchymal Stem Cell and Th17 Cell InterplayPatricia Luz-Crawford, Gabriel Espinosa-Carrasco, Natacha Ipseiz, et al.
Nature|November 30, 2021
An autoimmune stem-like CD8 T cell population drives type 1 diabetesSofia V Gearty, Friederike Dündar, Paul Zumbo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2019
Cytotoxic CD8<sup>+</sup> T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneuronsEmmanuelle Coque, Céline Salsac, Gabriel Espinosa-Carrasco, et al.
The Journal of Experimental Medicine|December 22, 2021
TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasionMojdeh Shakiba, Paul Zumbo, Gabriel Espinosa-Carrasco, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancer Cell|June 21, 2024
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumorsGabriel Espinosa-Carrasco, Edison Chiu, Aurora Scrivo, et al.
Theranostics|January 19, 2018
Gilz-Activin A as a Novel Signaling Axis Orchestrating Mesenchymal Stem Cell and Th17 Cell InterplayPatricia Luz-Crawford, Gabriel Espinosa-Carrasco, Natacha Ipseiz, et al.
Nature|November 30, 2021
An autoimmune stem-like CD8 T cell population drives type 1 diabetesSofia V Gearty, Friederike Dündar, Paul Zumbo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2019
Cytotoxic CD8<sup>+</sup> T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneuronsEmmanuelle Coque, Céline Salsac, Gabriel Espinosa-Carrasco, et al.
The Journal of Experimental Medicine|December 22, 2021
TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasionMojdeh Shakiba, Paul Zumbo, Gabriel Espinosa-Carrasco, et al.
Pageof 5